KEWAUNEE SCIENTIFIC CP (KEQU) Stock Fundamental Analysis
USA - NASDAQ:KEQU - US4928541048 - Common Stock
45.765 USD
+0.47 (+1.03%)
45.765 USD
0 (0%)
Overall KEQU gets a fundamental rating of 4 out of 10. We evaluated KEQU against 191 industry peers in the Health Care Equipment & Supplies industry. KEQU has only an average score on both its financial health and profitability. KEQU has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
KEQU had positive earnings in the past year.
In the past year KEQU had a positive cash flow from operations.
In multiple years KEQU reported negative net income over the last 5 years.
In multiple years KEQU reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 5.86%, KEQU belongs to the top of the industry, outperforming 83.25% of the companies in the same industry.
With an excellent Return On Equity value of 17.69%, KEQU belongs to the best of the industry, outperforming 92.67% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 9.80%, KEQU belongs to the top of the industry, outperforming 90.05% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for KEQU is in line with the industry average of 8.46%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.86% | ||
| ROE | 17.69% | ||
| ROIC | 9.8% |
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
1.3 Margins
KEQU has a Profit Margin of 4.74%. This is in the better half of the industry: KEQU outperforms 76.44% of its industry peers.
Looking at the Operating Margin, with a value of 7.39%, KEQU is in the better half of the industry, outperforming 75.92% of the companies in the same industry.
KEQU has a Gross Margin of 28.63%. This is in the lower half of the industry: KEQU underperforms 76.96% of its industry peers.
KEQU's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.39% | ||
| PM (TTM) | 4.74% | ||
| GM | 28.63% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
2. Health
2.1 Basic Checks
KEQU has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for KEQU remains at a similar level compared to 1 year ago.
KEQU has more shares outstanding than it did 5 years ago.
KEQU has a worse debt/assets ratio than last year.
2.2 Solvency
KEQU has an Altman-Z score of 2.97. This is not the best score and indicates that KEQU is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.97, KEQU is doing good in the industry, outperforming 69.11% of the companies in the same industry.
KEQU has a debt to FCF ratio of 5.19. This is a neutral value as KEQU would need 5.19 years to pay back of all of its debts.
The Debt to FCF ratio of KEQU (5.19) is better than 80.63% of its industry peers.
KEQU has a Debt/Equity ratio of 0.96. This is a neutral value indicating KEQU is somewhat dependend on debt financing.
KEQU's Debt to Equity ratio of 0.96 is on the low side compared to the rest of the industry. KEQU is outperformed by 76.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.96 | ||
| Debt/FCF | 5.19 | ||
| Altman-Z | 2.97 |
ROIC/WACC1.25
WACC7.83%
2.3 Liquidity
KEQU has a Current Ratio of 2.20. This indicates that KEQU is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 2.20, KEQU perfoms like the industry average, outperforming 40.31% of the companies in the same industry.
KEQU has a Quick Ratio of 1.59. This is a normal value and indicates that KEQU is financially healthy and should not expect problems in meeting its short term obligations.
KEQU has a Quick ratio (1.59) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.2 | ||
| Quick Ratio | 1.59 |
3. Growth
3.1 Past
KEQU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -71.96%.
The earnings per share for KEQU have been decreasing by -18.78% on average. This is quite bad
KEQU shows a decrease in Revenue. In the last year, the revenue decreased by -7.27%.
The Revenue has been growing slightly by 5.68% on average over the past years.
EPS 1Y (TTM)-71.96%
EPS 3Y-27.83%
EPS 5Y-18.78%
EPS Q2Q%N/A
Revenue 1Y (TTM)-7.27%
Revenue growth 3Y4.46%
Revenue growth 5Y5.68%
Sales Q2Q%46.92%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 53.84, which means the current valuation is very expensive for KEQU.
KEQU's Price/Earnings ratio is a bit cheaper when compared to the industry. KEQU is cheaper than 68.59% of the companies in the same industry.
KEQU's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.20.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 53.84 | ||
| Fwd PE | N/A |
4.2 Price Multiples
94.76% of the companies in the same industry are more expensive than KEQU, based on the Enterprise Value to EBITDA ratio.
KEQU's Price/Free Cash Flow ratio is rather cheap when compared to the industry. KEQU is cheaper than 96.34% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.7 | ||
| EV/EBITDA | 8.14 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for KEQU!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
45.765
+0.47 (+1.03%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners40.64%
Inst Owner Change-4.03%
Ins Owners16.04%
Ins Owner Change2.13%
Market Cap135.01M
Analysts82.86
Price TargetN/A
Short Float %2.44%
Short Ratio4.84
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 53.84 | ||
| Fwd PE | N/A | ||
| P/S | 0.56 | ||
| P/FCF | 10.7 | ||
| P/OCF | 9.13 | ||
| P/B | 2.09 | ||
| P/tB | 3.95 | ||
| EV/EBITDA | 8.14 |
EPS(TTM)0.85
EY1.86%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)4.28
FCFY9.35%
OCF(TTM)5.01
OCFY10.95%
SpS81.52
BVpS21.85
TBVpS11.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.86% | ||
| ROE | 17.69% | ||
| ROCE | 12.6% | ||
| ROIC | 9.8% | ||
| ROICexc | 10.96% | ||
| ROICexgc | 14.39% | ||
| OM | 7.39% | ||
| PM (TTM) | 4.74% | ||
| GM | 28.63% | ||
| FCFM | 5.25% |
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
ROICexc(3y)12.02%
ROICexc(5y)N/A
ROICexgc(3y)13.16%
ROICexgc(5y)N/A
ROCE(3y)12.97%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
F-Score5
Asset Turnover1.24
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.96 | ||
| Debt/FCF | 5.19 | ||
| Debt/EBITDA | 2.74 | ||
| Cap/Depr | 45.51% | ||
| Cap/Sales | 0.9% | ||
| Interest Coverage | 5.26 | ||
| Cash Conversion | 65.65% | ||
| Profit Quality | 110.63% | ||
| Current Ratio | 2.2 | ||
| Quick Ratio | 1.59 | ||
| Altman-Z | 2.97 |
F-Score5
WACC7.83%
ROIC/WACC1.25
Cap/Depr(3y)110.02%
Cap/Depr(5y)97.64%
Cap/Sales(3y)1.65%
Cap/Sales(5y)1.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-71.96%
EPS 3Y-27.83%
EPS 5Y-18.78%
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.27%
Revenue growth 3Y4.46%
Revenue growth 5Y5.68%
Sales Q2Q%46.92%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-16.94%
FCF growth 3YN/A
FCF growth 5Y49.49%
OCF growth 1Y-24.44%
OCF growth 3YN/A
OCF growth 5Y28.86%